Innovative Cellular Therapeutics
PrivateLast Round
Series C
Sep 6, 2021
Total Funding Raised
$96.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Innovative Cellular Therapeutics is a biotechnology company specializing in the development of chimeric antigen receptor T cell products aimed at treating blood cancers and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innovative Cellular Therapeutics Comparables
Compare Innovative Cellular Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Triumvira Immunologics | 85% | |
| A2 Biotherapeutics | 85% | |
| Inceptor Bio | 85% | |
Innovative Cellular Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 6, 2021 | ||||
| Series B Extension | Dec 18, 2019 | ||||
| Series B | Apr 24, 2018 | ||||
| Series A | Oct 1, 2016 |
Key People
Founding team and executive leadership
Innovative Cellular Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDH Investments | Series A, Series C |
| LongHash Ventures | Series B Extension |
| Linghang Ventures | Series B Extension |
| CDH VGC | Series C |
| Shenzhen GTJA Investment Group | Series B |
| Witruth Capital | Series B |
| Volcanics Venture | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 41% to 2.1K.
- Nov 11, 2025
Lyell Immunopharma acquired rights to LYL273 for cancer treatment.
Innovative Cellular Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Innovative Cellular Therapeutics's valuation, stock price, and market status.